A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Children with High Risk Kawasaki Disease (IND 127812)
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
11-2-2023
DOI
10.1182/blood-2023-184832
Journal Title
Blood
Department
Pediatrics
Second Department
Public Health
Recommended Citation
Schaefer, E., Shi, Q., Brandstaedter, K., Melchert, K., Patel, D., Morris, E., Fabricatore, S., Mintzer, E., DuFresne, J., Cooke, K. R., & Cairo, M. S. (2023). A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Children with High Risk Kawasaki Disease (IND 127812). Blood, 142 (Suppl. 1), 5412. https://doi.org/10.1182/blood-2023-184832
